A company has been approved to manufacture and sell the new drug, Acelex Cap, for the first time ever without any manufacturing facility
The Ministry of Food and Drug Safety (Minister Seung Jung) announced on the 5th to approve manufacturing and sales of the 22nd domestically developed new drug ‘Acelex Cap’ of CrystalGenomics.
‘Acelex Cap’, having ‘Polmacoxib’as a main component, is an anti-inflammatory agent to relax symptoms of...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
